nodes	percent_of_prediction	percent_of_DWPC	metapath
Pomalidomide—CYP1A2—Methoxsalen—vitiligo	0.639	0.656	CbGbCtD
Pomalidomide—CYP3A4—Methoxsalen—vitiligo	0.335	0.344	CbGbCtD
Pomalidomide—TNF—Cellular roles of Anthrax toxin—NLRP1—vitiligo	0.00396	0.15	CbGpPWpGaD
Pomalidomide—TNF—HIV-1 Nef: Negative effector of Fas and TNF-alpha—CASP7—vitiligo	0.00108	0.0408	CbGpPWpGaD
Pomalidomide—CYP1A2—Aflatoxin B1 metabolism—GSTM1—vitiligo	0.000889	0.0338	CbGpPWpGaD
Pomalidomide—TNF—FAS pathway and Stress induction of HSP regulation—CASP7—vitiligo	0.000886	0.0337	CbGpPWpGaD
Pomalidomide—TNF—TWEAK Signaling Pathway—CASP7—vitiligo	0.000886	0.0337	CbGpPWpGaD
Pomalidomide—PTGS2—Signaling mediated by p38-alpha and p38-beta—MITF—vitiligo	0.000782	0.0297	CbGpPWpGaD
Pomalidomide—TNF—Caspase Cascade in Apoptosis—GZMB—vitiligo	0.000758	0.0288	CbGpPWpGaD
Pomalidomide—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—CASP7—vitiligo	0.000736	0.028	CbGpPWpGaD
Pomalidomide—TNF—Amyotrophic lateral sclerosis (ALS)—CAT—vitiligo	0.000695	0.0264	CbGpPWpGaD
Pomalidomide—TNF—Caspase Cascade in Apoptosis—CASP7—vitiligo	0.000694	0.0264	CbGpPWpGaD
Pomalidomide—CYP3A4—Aflatoxin B1 metabolism—GSTM1—vitiligo	0.000686	0.0261	CbGpPWpGaD
Pomalidomide—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—vitiligo	0.000677	0.0257	CbGpPWpGaD
Pomalidomide—TNF—Downstream signaling in naïve CD8+ T cells—GZMB—vitiligo	0.000674	0.0256	CbGpPWpGaD
Pomalidomide—TNF—Allograft Rejection—GZMB—vitiligo	0.000584	0.0222	CbGpPWpGaD
Pomalidomide—TNF—Apoptosis—GZMB—vitiligo	0.000556	0.0211	CbGpPWpGaD
Pomalidomide—TNF—Allograft Rejection—CASP7—vitiligo	0.000535	0.0203	CbGpPWpGaD
Pomalidomide—TNF—Alzheimers Disease—CASP7—vitiligo	0.000535	0.0203	CbGpPWpGaD
Pomalidomide—TNF—Apoptosis—CASP7—vitiligo	0.000509	0.0193	CbGpPWpGaD
Pomalidomide—TNF—TNF alpha Signaling Pathway—CASP7—vitiligo	0.000473	0.018	CbGpPWpGaD
Pomalidomide—TNF—Allograft Rejection—CTLA4—vitiligo	0.00047	0.0178	CbGpPWpGaD
Pomalidomide—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—vitiligo	0.000469	0.0178	CbGpPWpGaD
Pomalidomide—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—vitiligo	0.000449	0.0171	CbGpPWpGaD
Pomalidomide—TNF—Folate Metabolism—CAT—vitiligo	0.000447	0.017	CbGpPWpGaD
Pomalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—vitiligo	0.000419	0.0159	CbGpPWpGaD
Pomalidomide—CYP1A2—Estrogen metabolism—GSTM1—vitiligo	0.000417	0.0159	CbGpPWpGaD
Pomalidomide—TNF—Downstream signaling in naïve CD8+ T cells—CD8A—vitiligo	0.000417	0.0158	CbGpPWpGaD
Pomalidomide—TNF—Downstream signaling in naïve CD8+ T cells—IL2RA—vitiligo	0.000376	0.0143	CbGpPWpGaD
Pomalidomide—TNF—Selenium Micronutrient Network—CAT—vitiligo	0.000355	0.0135	CbGpPWpGaD
Pomalidomide—TNF—Apoptosis—GZMB—vitiligo	0.000341	0.0129	CbGpPWpGaD
Pomalidomide—TNF—Allograft Rejection—IL2RA—vitiligo	0.000326	0.0124	CbGpPWpGaD
Pomalidomide—CYP3A4—Estrogen metabolism—GSTM1—vitiligo	0.000322	0.0122	CbGpPWpGaD
Pomalidomide—TNF—Apoptosis—CASP7—vitiligo	0.000312	0.0118	CbGpPWpGaD
Pomalidomide—TNF—MAPK Signaling Pathway—CASP7—vitiligo	0.000292	0.0111	CbGpPWpGaD
Pomalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—vitiligo	0.00029	0.011	CbGpPWpGaD
Pomalidomide—TNF—Allograft Rejection—CD80—vitiligo	0.000272	0.0103	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—CASP7—vitiligo	0.000264	0.01	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—GZMB—vitiligo	0.000256	0.00973	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—CASP7—vitiligo	0.000234	0.00891	CbGpPWpGaD
Pomalidomide—TNF—Toll-like Receptor Signaling Pathway—CD80—vitiligo	0.000221	0.00842	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—CAT—vitiligo	0.000219	0.00834	CbGpPWpGaD
Pomalidomide—PTGS2—C-MYB transcription factor network—GSTM1—vitiligo	0.000215	0.00817	CbGpPWpGaD
Pomalidomide—CYP1A2—Tryptophan metabolism—CAT—vitiligo	0.000209	0.00793	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—CTLA4—vitiligo	0.000206	0.00782	CbGpPWpGaD
Pomalidomide—CYP1A2—Phase II conjugation—GSTT1—vitiligo	0.000184	0.007	CbGpPWpGaD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—CD80—vitiligo	0.000173	0.00657	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—CASP7—vitiligo	0.000163	0.0062	CbGpPWpGaD
Pomalidomide—CYP3A4—Tryptophan metabolism—CAT—vitiligo	0.000161	0.00612	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—IL2RA—vitiligo	0.000143	0.00542	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—CD80—vitiligo	0.000119	0.00453	CbGpPWpGaD
Pomalidomide—CYP1A2—Phase II conjugation—GSTM1—vitiligo	0.000117	0.00446	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP7—vitiligo	0.000116	0.0044	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—GSTT1—vitiligo	0.000108	0.00409	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—GSTT1—vitiligo	8.31e-05	0.00316	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—GSTM1—vitiligo	6.86e-05	0.00261	CbGpPWpGaD
Pomalidomide—CYP1A2—Metapathway biotransformation—GSTM1—vitiligo	6.77e-05	0.00257	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—GSTM1—vitiligo	5.29e-05	0.00201	CbGpPWpGaD
Pomalidomide—CYP3A4—Metapathway biotransformation—GSTM1—vitiligo	5.22e-05	0.00198	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GSTT1—vitiligo	3.25e-05	0.00124	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CD44—vitiligo	3.23e-05	0.00123	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CD44—vitiligo	2.71e-05	0.00103	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GSTT1—vitiligo	2.31e-05	0.000877	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CAT—vitiligo	2.2e-05	0.000834	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GSTM1—vitiligo	2.07e-05	0.000788	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CD44—vitiligo	1.92e-05	0.000729	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GSTT1—vitiligo	1.84e-05	0.0007	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CD80—vitiligo	1.84e-05	0.0007	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CAT—vitiligo	1.56e-05	0.000591	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CD44—vitiligo	1.53e-05	0.000582	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GSTM1—vitiligo	1.47e-05	0.000558	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GSTT1—vitiligo	1.42e-05	0.00054	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CAT—vitiligo	1.24e-05	0.000472	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CD44—vitiligo	1.18e-05	0.000449	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GSTM1—vitiligo	1.17e-05	0.000446	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CAT—vitiligo	9.59e-06	0.000364	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GSTM1—vitiligo	9.05e-06	0.000344	CbGpPWpGaD
